PROGRAF 0.5mg capsules ASTELLAS
Active substance: tacrolimus
Indicated for: prevention of transplant rejection
Find medicines for human use by name or active substance.
Browse by initial
1,261–1,280 of 1,444 medicines
Active substance: tacrolimus
Indicated for: prevention of transplant rejection
Active substance: tacrolimus
Indicated for: prevention of transplant rejection
Active substance: tacrolimus
Indicated for: prevention of transplant rejection
Active substance: tacrolimus
Indicated for: prevention of transplant rejection
Active substance: gadoteridol
V08CA04 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
Active substance: gadoteridol
V08CA04 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
Active substance: gadoteridol
V08CA04 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
Active substance: denosumab
Indicated for: osteoporosis; bone metastases; tumor-induced hypercalcemia
Active substance: progesterone
G03DA04 Genito urinary system and sex hormones | Progestogens | Pregnen (4) derivatives
Indicated for: disorders associated with progesterone deficiency
Active substance: progesterone
G03DA04 Genito urinary system and sex hormones | Progestogens | Pregnen (4) derivatives
Indicated for: disorders associated with progesterone deficiency
Active substance: vitamins + minerals
A11AA03 Alimentary tract and metabolism | Multivitamins, combinations | Multivitamins with minerals
Indicated for: vitamin deficiency
Active substance: trimebutin
Indicated for: gastrointestinal spasms; functional abdominal pain
Active substance: rivastigmine
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
Indicated for: Alzheimer's disease; dementia
Active substance: rivastigmine
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
Indicated for: Alzheimer's disease; dementia
Active substance: rivastigmine
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
Indicated for: Alzheimer's disease; dementia
Active substance: rivastigmine
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
Indicated for: Alzheimer's disease; dementia
Active substance: rivastigmine
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
Indicated for: Alzheimer's disease; dementia
Active substance: rivastigmine
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
Indicated for: Alzheimer's disease; dementia
Active substance: rivastigmine
N06DA03 Nervous system | Anti-dementia drugs | Anticholinesterases
Indicated for: Alzheimer's disease; dementia
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.